CPT code 82103 represents a quantitative laboratory measurement of total alpha–1–antitrypsin in serum or plasma, used to detect hereditary deficiency and to aid evaluation of chronic obstructive pulmonary disease nationally. As a clinical laboratory analyte, this test informs diagnosis and disease management decisions for respiratory and hereditary conditions and is performed in hospital and outpatient laboratory settings. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for the test, typical sites of service, and payer coverage relevance. The publication also summarizes expected billing practice considerations, common modifiers associated with laboratory services, and the role of the test within diagnostic workflows for COPD and alpha–1–antitrypsin deficiency. Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service-line specifics is noted where applicable.